Medtronic plc. (MDT)
| Market Cap | 144.57B |
| Revenue (ttm) | 31.80B |
| Net Income (ttm) | 4.70B |
| Shares Out | 1.34B |
| EPS (ttm) | 3.47 |
| PE Ratio | 31.00 |
| Forward PE | 19.69 |
| Dividend | $2.47 (2.30%) |
| Ex-Dividend Date | Dec 21, 2021 |
| Volume | 4,171,247 |
| Open | 107.01 |
| Previous Close | 108.55 |
| Day's Range | 106.32 - 108.21 |
| 52-Week Range | 98.38 - 135.89 |
| Beta | 0.81 |
| Analysts | Buy |
| Price Target | 131.64 (+22.4%) |
| Earnings Date | n/a |
About MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX product...
Financial Performance
Financial StatementsAnalyst Forecast
According to 28 analysts, the average rating for Medtronic plc. stock is "Buy." The 12-month stock price forecast is 131.64, which is an increase of 22.43% from the latest price.
News
Medtronic's (MDT) DTM SCS Endurance Therapy Study Data Positive
Medtronic's (MDT) DTM SCS endurance therapy offers meaningful clinical benefits by reducing pain, improving quality of life and offering meaningful device longevity for patients.
Medtronic's Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief
Medtronic plc (NYSE: MDT) announced three-month results from an on-label, prospective, multi-center study of Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) pain therapy. The data sh...
Medtronic announces results showing meaningful pain relief using DTM™ Spinal Cord Stimulation endurance therapy
DTM™ SCS endurance therapy enables long-lasting recharge-free performance on Vanta™ and 5-minute recharge on Intellis™ neurostimulators DUBLIN, Jan. 14, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a...
1 Green Flag for Medtronic in 2022, and 1 Red Flag
When the stock price follows the action of the FDA, investors hope the news is good.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
Medtronic (MDT) closed at $108.95 in the latest trading session, marking a +0.98% move from the prior day.
Medtronic (MDT) Gets MHLW Approval for Micra AV Sale in Japan
The Micra AV approval is likely to boost Medtronic's (MDT) Cardiac Rhythm Management business while delivering the benefits of leadless pacing in Japan.
Medtronic announces schedule for presentations at the 2022 North American Neuromodulation Society Meeting
Sessions will include DTM™ SCS endurance therapy 3-month outcomes for patients with chronic back and leg pain DUBLIN, Jan. 12, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcar...
Medtronic (MDT) to Buy Affera, Expand in Electrophysiology
Affera's full suite of solutions and technologies will complement Medtronic's (MDT) existing atrial and ventricular arrhythmia disease management portfolio.
Medtronic's Leadless Micra AV Pacing System Scores Approval In Japan
Japan's Ministry of Health, Labor, and Welfare has approved Medtronic plc's (NYSE: MDT) Micra AV Transcatheter Pacing System (TPS). The Company will launch the product this month.
Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System
DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare for ...
Medtronic's Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera
Medtronic Plc's (NYSE: MDT) CoreValve Evolut Pro TAVR system has received National Medical Products Administration approval in China. The approval marks the first Medtronic TAVR system approved in China...
Medtronic Announces Approval of the Evolut™ PRO TAVR System in China
First Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technolog...
Medtronic to Acquire Affera
Acquisition to expand company's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest growing medtech markets DUBLIN, Jan. 10, 2022 /PRNewswire/ -...
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Diversification is key in investing!
What's Happening With Medtronic Stock?
The stock price of Medtronic has seen a fall of 4% over the last month, underperforming the broader indices, with the S&P 500 rising 2% over the same period. This underperformance can largely be attribu...
2 Stocks That Could Set You Up for Life
Both of these stocks have lagged the market in the past year, but don't let that scare you away.
Medtronic (MDT) Gains As Market Dips: What You Should Know
Medtronic (MDT) closed the most recent trading day at $106.39, moving +0.27% from the previous trading session.
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate virtually in the 40th annual J.P. Morgan healthcare conferen...
Titan Medical Completes Final Milestone Under Development Agreement with Medtronic
TORONTO--(BUSINESS WIRE)--Titan Medical Completes Final Milestone under Development Agreement with Medtronic
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Medtronic (MDT) closed the most recent trading day at $103.95, moving -0.55% from the previous trading session.
Should You Buy This Beaten-Down Blue-Chip Stock?
Medtronic's stock has significantly lagged the S&P 500 this year for a variety of reasons.
7 Stock Bargains Worth a Look After the Most Recent Pullback
Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors. The post 7 Stock Bargains Worth a Look After the Most Recent Pullback appe...
Medtronic (MDT) to Gain From Expanded Medicare Coverage for CGM
CMS' expanded Medicare coverage includes continuous glucose monitors that can be integrated with Medtronic's (MDT) insulin pumps.
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
4 Internet of Medical Things (IoMT) Stocks to Buy for 2022
Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.